PATENT CLAIM ANALYSIS

Application Number: 16066574
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "234500"]

Abstract:
A novel class of fluorinated derivatives of Formula (I) have been prepared and found to be useful in the treatment of cancers and other EGFR related disorders.

Claim (Index 13):
The compound of  claim 11 , wherein X 1 , X 2  and X 3  are the same or different and are selected from H, F and C 1-4 alkyl.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 94.0
- Lexical Diversity: 1.11111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14466896', '15359370', '14234514', '14002983', '14399510']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7820813027404472
- 35 USC 102 Novelty (BERT): 0.5138420409596798
- Combined Prediction Score: 0.7552573765623705
- Mean Citation Score: 272.126818
- Max Citation Score: 283.61575
- Similarity Product: 213.75700346559285

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test